ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 68 filers reported holding ADC THERAPEUTICS SA in Q3 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,377,275 | -22.4% | 2,650,251 | +86.1% | 0.00% | -50.0% |
Q2 2023 | $3,061,920 | +87458.5% | 1,424,149 | -20.6% | 0.00% | 0.0% |
Q1 2023 | $3,497 | -73.2% | 1,793,192 | -47.3% | 0.00% | -71.4% |
Q4 2022 | $13,060 | -99.4% | 3,401,120 | +709.3% | 0.01% | +600.0% |
Q3 2022 | $2,026,000 | +339.5% | 420,253 | +625.0% | 0.00% | – |
Q2 2022 | $461,000 | -43.4% | 57,965 | +43.6% | 0.00% | – |
Q4 2021 | $815,000 | -14.2% | 40,367 | +36.0% | 0.00% | -100.0% |
Q4 2020 | $950,000 | -9.3% | 29,679 | -6.5% | 0.00% | 0.0% |
Q3 2020 | $1,047,000 | +50.2% | 31,747 | +113.3% | 0.00% | 0.0% |
Q2 2020 | $697,000 | – | 14,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |